Tcr2 Therapeutics Inc

NASDAQ:TCRR   3:59:26 PM EDT
27.78
+1.21 (+4.55%)
Earnings Announcements

Tcr² Therapeutics Reports Third Quarter 2020 Financial Results And Provides Corporate Update

Published: 11/12/2020 11:56 GMT
Tcr2 Therapeutics Inc (TCRR) - Tcr² Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update.
Tcr2 Therapeutics Inc Qtrly Loss per Share 56 Cents.
Tcr2 Therapeutics Inc - Projects Net Cash Use of $65-70 Million for 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.55

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.56

More details on our Analysts Page.